"the csl behring facility in kankakee, illinois, has an initial capacity of processing approximately 500,000 liters of plasma annually, with expansions increasing base fractionation capacity by 140% and albumin production capacity"
But doing a search a bit more thoroughly I got this one from 2016 which is more promising. That was 9 years ago so they may now be up there with similar volume to Grifols, and more honest too.
And CSL Behring continues to expand in Kankakee. Later this year they will complete one of their largest construction projects, called Everest. Everest is only 7 floors, but it is equal in size to a 17 story building. Once completed, the Everest Project will expand the facility's capacity by 8 million liters a year.
CSL Price at posting:
$233.62 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)